Cargando…

Dexamethasone: Acute pulmonary histoplasmosis following Off-label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532420/ http://dx.doi.org/10.1007/s40278-021-04164-2

Ejemplares similares

Dexamethasone: Pulmonary mucormycosis following off-label use: case report
Publicado: (2021)

Dexamethasone: Invasive pulmonary aspergillosis following off-label use: case report
Publicado: (2021)

Dexamethasone: Histoplasmosis: case report
Publicado: (2021)

Dexamethasone: Hyperglycaemia following off-label use: case report
Publicado: (2022)

Dexamethasone: Pulmonary mucormycosis, pulmonary aspergillosis and off-label use: case report
Publicado: (2021)

Dexamethasone: Adrenal insufficiency following off-label use: case report
Publicado: (2021)

Dexamethasone: Endogenous endophthalmitis following off-label use: case report
Publicado: (2021)

Dexamethasone: Nocardia infection followed by off-label use: case report
Publicado: (2021)

Dexamethasone: Adrenal insufficiency following off-label use : case report
Publicado: (2021)

Dexamethasone: Lack of efficacy following off-label use: case report
Publicado: (2022)

Ceftriaxone/doxycycline/immunosuppressants: Disseminated histoplasmosis following an off label use and lack of efficacy: case report
Publicado: (2022)

Dexamethasone: Chronic cavitary pulmonary aspergillosis and off label use: case report
Publicado: (2022)

Azithromycin/dexamethasone/voriconazole: Pulmonary aspergillosis following off-label use, and lack of efficacy: case report
Publicado: (2021)

Dexamethasone: Bone marrow necrosis following off label treatment with dexamethasone: case report
Publicado: (2022)

Dexamethasone: Fulminant amoebic colitis following off-label use: case report
Publicado: (2021)

Dexamethasone: Glucocorticoid-induced hyperglycaemia following off label use : case report
Publicado: (2022)

Dexamethasone: Sino-orbital mucormycosis following off-label use: case report
Publicado: (2022)

Dexamethasone/hydrocortisone/methylprednisolone: Disseminated cryptococcosis following off label use of dexamethasone, hydrocortisone and methylprednisolone: case report
Publicado: (2022)

Dexamethasone: Disseminated coccidioidomycosis and off label use: case report
Publicado: (2021)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone: Various toxicities and off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/piperacillin/tazobactam: Lack of efficacy following off-label use: case report
Publicado: (2021)

Dexamethasone: Reactivation of Strongyloides stercoralis following off-label use: 2 case reports
Publicado: (2021)

Dexamethasone/methylprednisolone: Various toxicities following off label use: 21 case reports
Publicado: (2022)

Aciclovir/dexamethasone/remdesivir: Lack of efficacy following off-label use: case report
Publicado: (2022)

Dexamethasone/methylprednisolone: Osteonecrosis of the knee following off-label use: 2 case reports
Publicado: (2022)

Ceftriaxone/dexamethasone/levofloxacin: Lack of efficacy following off-label use: case report
Publicado: (2022)

Dexamethasone: Elizabethkingia meningoseptica sepsis following off-label treatment: case report
Publicado: (2021)

Dexamethasone/tocilizumab: Lack of efficacy following off-label therapy: case report
Publicado: (2022)

Dexamethasone: Spontaneous pneumomediastinum and subcutaneous emphysema following off label use: 4 case reports
Publicado: (2021)

Dexamethasone/tocilizumab: Rhino-orbital mucormycosis following off-label use: 11 case reports
Publicado: (2021)

Dexamethasone/methylprednisolone/prednisolone: Avascular necrosis following off-label use:3 case reports
Publicado: (2021)

Dexamethasone/enoxaparin-sodium/remdesivir: Lack of efficacy following off-label use: case report
Publicado: (2021)

Dexamethasone/methylprednisolone: Sino-orbital mucormycosis infection following off label use: case report
Publicado: (2021)

Dexamethasone/tocilizumab/tofacitinib: Lack of efficacy following off label use: 2 case reports
Publicado: (2022)

Baricitinib/dexamethasone: Myalgia and elevated creatine kinase following an off-label use: case report
Publicado: (2022)

Dexamethasone/voriconazole: Invasive aspergillosis following off-label use; lack of efficacy: case report
Publicado: (2022)

Dexamethasone/methylprednisolone/tocilizumab: Fatal disseminated mucormycosis following off-label use: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ms4eqk7abmgvju5ai3k0n3cc0f